Hart AL - Search Results

1

Commentary: Predicting response to ciclosporin in acute severe ulcerative colitis.

Peake ST, Hart AL. Peake ST, et al. Among authors: hart al. Aliment Pharmacol Ther. 2012 Dec;36(11-12):1095-6; discussion 1096-7. doi: 10.1111/apt.12066. Aliment Pharmacol Ther. 2012. PMID: 23130766 No abstract available.

2

The role of the gut flora in health and disease, and its modification as therapy.

Hart AL, Stagg AJ, Frame M, Graffner H, Glise H, Falk P, Kamm MA. Hart AL, et al. Aliment Pharmacol Ther. 2002 Aug;16(8):1383-93. doi: 10.1046/j.1365-2036.2002.01310.x. Aliment Pharmacol Ther. 2002. PMID: 12182739 Review.

3

Review article: mechanisms of initiation and perpetuation of gut inflammation by stress.

Hart A, Kamm MA. Hart A, et al. Aliment Pharmacol Ther. 2002 Dec;16(12):2017-28. doi: 10.1046/j.1365-2036.2002.01359.x. Aliment Pharmacol Ther. 2002. PMID: 12452934 Review.

4

Azathioprine dose escalation in inflammatory bowel disease.

Rayner CK, Hart AL, Hayward CM, Emmanuel AV, Kamm MA. Rayner CK, et al. Among authors: hart al. Aliment Pharmacol Ther. 2004 Jul 1;20(1):65-71. doi: 10.1111/j.1365-2036.2004.02009.x. Aliment Pharmacol Ther. 2004. PMID: 15225172

5

Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.

Russo EA, Harris AW, Campbell S, Lindsay J, Hart A, Arebi N, Milestone A, Tsai HH, Walters J, Carpani M, Westaby D, Thillainayagam A, Bansi D, Ghosh S. Russo EA, et al. Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14. doi: 10.1111/j.1365-2036.2008.03890.x. Epub 2008 Nov 13. Aliment Pharmacol Ther. 2009. PMID: 19035973

6

Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.

Ng SC, Plamondon S, Kamm MA, Hart AL, Al-Hassi HO, Guenther T, Stagg AJ, Knight SC. Ng SC, et al. Among authors: al hassi ho, hart al. Inflamm Bowel Dis. 2010 Aug;16(8):1286-98. doi: 10.1002/ibd.21222. Inflamm Bowel Dis. 2010. PMID: 20155842 Clinical Trial.

7

Review article: the optimal medical management of acute severe ulcerative colitis.

Hart AL, Ng SC. Hart AL, et al. Aliment Pharmacol Ther. 2010 Sep;32(5):615-27. doi: 10.1111/j.1365-2036.2010.04392.x. Aliment Pharmacol Ther. 2010. PMID: 20626381 Review.

8

Review article: medical, surgical and radiological management of perianal Crohn's fistulas.

Tozer PJ, Burling D, Gupta A, Phillips RK, Hart AL. Tozer PJ, et al. Among authors: hart al. Aliment Pharmacol Ther. 2011 Jan;33(1):5-22. doi: 10.1111/j.1365-2036.2010.04486.x. Epub 2010 Oct 29. Aliment Pharmacol Ther. 2011. PMID: 21083581 Review.

9

Vulval Crohn's disease: a tertiary center experience of 23 patients.

Landy J, Peake ST, Akbar A, Hart AL. Landy J, et al. Among authors: hart al. Inflamm Bowel Dis. 2011 Jul;17(7):E77. doi: 10.1002/ibd.21755. Epub 2011 Apr 28. Inflamm Bowel Dis. 2011. PMID: 21538719 No abstract available.

10

Patient preference in choosing biological therapy in Crohn's disease.

Peake ST, Landy J, Hussein M, Tee CT, O'Connor M, Tyrrell T, Akbar A, Hart AL. Peake ST, et al. Among authors: hart al. Inflamm Bowel Dis. 2011 Jul;17(7):E79. doi: 10.1002/ibd.21767. Epub 2011 May 1. Inflamm Bowel Dis. 2011. PMID: 21538722 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters